National Cancer Institute  www.cancer.gov  U.S. National Institutes of Health
 


Cancer Trends Progress Report – 2009/2010 Update

Skip to content
Progress Report  Home

Progress Report Tools
 Print this page
 Generate custom report



In the Report
Introduction
Trends-at-a-Glance
Summary Tables
Prevention
Early Detection
Diagnosis
Treatment
Bladder Cancer Treatment
Breast Cancer Treatment
Colorectal Cancer Treatment
Kidney Cancer Treatment
Lung Cancer Treatment
Ovarian Cancer Treatment
> Prostate Cancer Treatment
Life After Cancer
End of Life



Prostate Cancer Treatment
Treatment

The use of hormonal therapy for localized/regional disease increased with the age of the patient.

On this page:

Benefits of Treatment

A meta-analysis comparing early hormonal therapy with hormonal therapy given later to men with locally advanced prostate cancer found a decrease in overall mortality for those who received early hormonal therapy, whether or not the patient had other treatment. Hormonal therapy is currently recommended for men at high risk of recurrence.

Back to Top

Measure

Hormonal therapy following the diagnosis of prostate cancer.

Back to Top

Period – 1998 and 2002

Back to Top

Trends –Between 1998 and 2002 there were no significant changes in the use of hormonal therapy.

Back to Top

Most Recent Estimates

The percentage of men with localized/regional prostate cancer given hormonal therapy was highest for those aged 80 years or older (52 percent) and lowest for men aged 40–49 years and 50–59 years (17 percent).

Back to Top

Healthy People 2010 Targets

There are no Healthy People 2010 targets for prostate cancer treatment.

Back to Top

Key Issues

Currently hormone therapy is recommended only for patients at high risk of recurrence. Zeliadt found that in 1999 African-American men aged 65 years or older were less often given androgen depravation therapy than were White men.

Back to Top

Additional Information on Prostate Cancer Treatment

Back to Top

Back: Ovarian Cancer Treatment

National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthUSA.gov